Methyl indole-1-carboxylate
| Common Name: |
Methyl indole-1-carboxylate |
| IUPAC Name: |
methyl indole-1-carboxylate |
| Molecular Formula: |
C5H10S2 |
| SMILES: |
COC(=O)N1C=CC2=CC=CC=C21 |
| Inchi: |
1S/C10H9NO2/c1-13-10(12)11-7-6-8-4-2-3-5-9(8)11/h2-7H,1H3 |
| Inchi Key: |
FHOPBCYBMWVMGJ-UHFFFAOYSA-N |
| Cas No: |
39203-20-8 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
3 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
134.26 |
| Mass (g/mol) |
175.063 |
| Molar Refractivity |
39.22 |
| Net Charge |
|
| HBD |
|
| HBA |
0 |
| Rt Bonds |
0 |
| Rings |
2 |
| TPSA |
50.60 |
| Hetero Atoms |
3 |
| Heavy Atoms |
7 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
290.96 |
| Vapor Pressure (mmHg@25.00 °C) |
0.002 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
1.00 |
| LogP |
2.256 |
| iLOGP |
2.05 |
| XLOGP3 |
1.91 |
| WLOGP |
2.55 |
| MLOGP |
1.83 |
| ESOL Log S |
-1.88 |
| ESOL Solubility (mg/ml) |
1.79 |
| ESOL Solubility (mol/l) |
0.013 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-2.60 |
| Ali Solubility (mg/ml) |
0.34 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-1.21 |
| Silicos-IT Solubility (mg/ml) |
8.24 |
| Silicos-IT Solubility (mol/l) |
0.06 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.76 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.767 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.293 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
